Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunological Measurement of Aspartate/Alanine Aminotransferase Utilizing Monoclonal Anti-bodies in Predicting Liver Fibrosis and Inflammation

NCT03562585 is registered in ClinicalTrials.gov with Chuncheon Sacred Heart Hospital as lead sponsor.

NCT NCT03562585
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03562585 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunological Measurement of Aspartate/Alanine Aminotransferase Utilizing Monoclonal Anti-bodies in Predicting Liver Fibrosis and Inflammation
Lead sponsor
Chuncheon Sacred Heart Hospital
Phase
Observational
Overall status
Completed
Start date
January 1, 2007
Completion date
March 2, 2017
Enrollment
219 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic liver disease and cirrhosis